4//SEC Filing
Levine James E. 4
Accession 0001209191-20-057806
CIK 0001610618other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 6:00 AM ET
Size
6.1 KB
Accession
0001209191-20-057806
Insider Transaction Report
Form 4
Levine James E.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-11-10$2.01/sh+50,000$100,720→ 50,000 total(indirect: By Spouse)
Holdings
- 65,834
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.97 to $2.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
- [F2]Includes 3,943 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2020.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001463151
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 6:00 AM ET
- Size
- 6.1 KB